Precision BioSciences (DTIL) Revenue & Revenue Breakdown
Precision BioSciences Revenue Highlights
Latest Revenue (Y)
$48.73M
Latest Revenue (Q)
$49.90M
Main Segment (Y)
Therapeutics Segment
Main Geography (Y)
Therapeutics Segment
Precision BioSciences Revenue by Period
Precision BioSciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $48.73M | 94.15% |
| 2022-12-31 | $25.10M | -78.28% |
| 2021-12-31 | $115.53M | 375.72% |
| 2020-12-31 | $24.29M | 9.20% |
| 2019-12-31 | $22.24M | 104.34% |
| 2018-12-31 | $10.88M | 67.84% |
| 2017-12-31 | $6.48M | - |
Precision BioSciences generated $48.73M in revenue during NA 2023, up 94.15% compared to the previous quarter, and up 447.73% compared to the same period a year ago.
Precision BioSciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $49.90M | 183.77% |
| 2024-03-31 | $17.58M | 149.84% |
| 2023-12-31 | $7.04M | -46.36% |
| 2023-09-30 | $13.12M | -33.70% |
| 2023-06-30 | $19.79M | 125.39% |
| 2023-03-31 | $8.78M | -17.15% |
| 2022-12-31 | $10.60M | 43.94% |
| 2022-09-30 | $7.36M | 92.75% |
| 2022-06-30 | $3.82M | 15.16% |
| 2022-03-31 | $3.32M | -47.67% |
| 2021-12-31 | $6.34M | -73.63% |
| 2021-09-30 | $24.04M | -65.07% |
| 2021-06-30 | $68.81M | 320.85% |
| 2021-03-31 | $16.35M | 84.82% |
| 2020-12-31 | $8.85M | 20.14% |
| 2020-09-30 | $7.36M | 583.02% |
| 2020-06-30 | $1.08M | -84.60% |
| 2020-03-31 | $7.00M | 7.30% |
| 2019-12-31 | $6.52M | 34.06% |
| 2019-09-30 | $4.87M | -9.72% |
| 2019-06-30 | $5.39M | -1.34% |
| 2019-03-31 | $5.46M | 10.57% |
| 2018-12-31 | $4.94M | 94.41% |
| 2018-09-30 | $2.54M | 35.59% |
| 2018-06-30 | $1.87M | 22.64% |
| 2018-03-31 | $1.53M | - |
Precision BioSciences generated $49.90M in revenue during Q2 2024, up 183.77% compared to the previous quarter, and up 568.31% compared to the same period a year ago.
Precision BioSciences Revenue Breakdown
Precision BioSciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|
| Therapeutics Segment | $111.72M | $21.86M | $20.63M |
| Food Segment | $3.81M | $2.42M | $1.61M |
Precision BioSciences's latest annual revenue breakdown by segment (product or service), as of Dec 21: Therapeutics Segment (96.71%), and Food Segment (3.29%).
Quarterly Revenue by Product
| Product/Service | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Therapeutics Segment | $5.36M | $22.80M | $67.89M | $15.68M | $8.32M | $7.05M | $1.02M | $5.47M | $6.28M | $4.72M | $4.82M | $4.82M |
| Food Segment | $977.00K | $1.24M | $918.00K | $670.00K | $524.00K | $315.00K | $58.00K | $1.52M | $247.00K | $146.00K | $570.00K | $643.00K |
Precision BioSciences's latest quarterly revenue breakdown by segment (product or service), as of Dec 21: Therapeutics Segment (84.59%), and Food Segment (15.41%).
Precision BioSciences Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|
| Food Segment | $3.81M | $2.42M | $1.61M |
| Therapeutics Segment | $111.72M | $21.86M | $20.63M |
Precision BioSciences's latest annual revenue breakdown by geography, as of Dec 21: Therapeutics Segment (96.71%), and Food Segment (3.29%).
Quarterly Revenue by Country
| Country | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Food Segment | $977.00K | $1.24M | $918.00K | $670.00K | $524.00K | $315.00K | $58.00K | $1.52M | $247.00K | $146.00K | $570.00K | $643.00K |
| Therapeutics Segment | $5.36M | $22.80M | $67.89M | $15.68M | $8.32M | $7.05M | $1.02M | $5.47M | $6.28M | $4.72M | $4.82M | $4.82M |
Precision BioSciences's latest quarterly revenue breakdown by geography, as of Dec 21: Therapeutics Segment (84.59%), and Food Segment (15.41%).
Precision BioSciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ALEC | Alector | $97.06M | $15.89M |
| DTIL | Precision BioSciences | $48.73M | $49.90M |
| HOOK | HOOKIPA Pharma | $20.13M | - |
| RVMD | Revolution Medicines, Inc. Warrant | $11.58M | - |
| MREO | Mereo BioPharma Group | $10.00M | - |
| STOK | Stoke Therapeutics | $8.78M | $4.22M |
| CYTK | Cytokinetics | $7.53M | $249.00K |
| PLRX | Pliant Therapeutics | $1.58M | - |
| BDTX | Black Diamond Therapeutics | - | - |
| XFOR | X4 Pharmaceuticals | - | $563.00K |
| DAWN | Day One Biopharmaceuticals | - | $20.07M |
| ABOS | Acumen Pharmaceuticals | - | - |
| INZY | Inozyme Pharma | - | - |
| DYN | Dyne Therapeutics | - | - |
| PASG | Passage Bio | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| ELDN | Eledon Pharmaceuticals | - | - |
DTIL Revenue FAQ
What is Precision BioSciences’s yearly revenue?
Precision BioSciences's yearly revenue for 2023 was $48.73M, representing an increase of 94.15% compared to 2022. The company's yearly revenue for 2022 was $25.1M, representing a decrease of -78.28% compared to 2021. DTIL's yearly revenue for 2021 was $115.53M, representing an increase of 375.72% compared to 2020.
What is Precision BioSciences’s quarterly revenue?
Precision BioSciences's quarterly revenue for Q2 2024 was $49.9M, a 183.77% increase from the previous quarter (Q1 2024), and a 152.15% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $17.58M, a 149.84% increase from the previous quarter (Q4 2023), and a 100.27% increase year-over-year (Q1 2023). DTIL's quarterly revenue for Q4 2023 was $7.04M, a -46.36% decrease from the previous quarter (Q3 2023), and a -33.59% decrease year-over-year (Q4 2022).
What is Precision BioSciences’s revenue growth rate?
Precision BioSciences's revenue growth rate for the last 3 years (2021-2023) was -57.82%, and for the last 5 years (2019-2023) was 119.12%.
What are Precision BioSciences’s revenue streams?
Precision BioSciences's revenue streams in c 21 are Therapeutics Segment, and Food Segment. Therapeutics Segment generated $111.72M in revenue, accounting 96.71% of the company's total revenue, up 411.01% year-over-year. Food Segment generated $3.81M in revenue, accounting 3.29% of the company's total revenue, up 57.14% year-over-year.
What is Precision BioSciences’s main source of revenue?
For the fiscal year ending Dec 21, the largest source of revenue of Precision BioSciences was Therapeutics Segment. This segment made a revenue of $111.72M, representing 96.71% of the company's total revenue.